HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain

Women's health
Hope Medicine hopes its HMI-115, a prolactin inhibitor, could tackle endometriosis-associated pain in the first-line setting. • Source: Shutterstock

More from R&D

More from Scrip